ArticleNature medicine1998
PPARgamma and colorectal carcinoma: conflicts in a nuclear family.
Article in Nature medicine, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 45 citations in OpenAlex.
- PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells.PPAR research · 2011Article
- Clinical Use of PPARgamma Ligands in Cancer.PPAR research · 2008Article
- Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients' survival.Digestive diseases and sciences · 2007Article
- The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells.Proceedings of the National Academy of Sciences of the United States of America · 2005Article
- PPAR gamma signaling exacerbates mammary gland tumor development.Genes & development · 2004Article
- Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control.Journal of biomedicine & biotechnology · 2004Article
- Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.The Journal of clinical investigation · 2003Article
- Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease.Comparative hepatology · 2003Article
- Insulin resistance, diabetes, and atherosclerosis: thiazolidinediones as therapeutic interventions.Current cardiology reports · 2002Review
- Peroxisome proliferator-activated receptor gamma (PPargamma) as a novel target for prostate cancer.Investigational new drugs · 2002Review
- Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor alpha-regulated gene expression.Proceedings of the National Academy of Sciences of the United States of America · 1999Article
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.